2931 related articles for article (PubMed ID: 33720396)
1. Interventions for preventing thrombosis in solid organ transplant recipients.
Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012467. PubMed ID: 33314078
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012467. PubMed ID: 32164041
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
[TBL] [Abstract][Full Text] [Related]
5. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation for people receiving long-term haemodialysis.
Natale P; Palmer SC; Ruospo M; Longmuir H; Dodds B; Prasad R; Batt TJ; Jose MD; Strippoli GF
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD011858. PubMed ID: 38189593
[TBL] [Abstract][Full Text] [Related]
7. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Vernooij RW; Michael M; Ladhani M; Webster AC; Strippoli GF; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2024 May; 5(5):CD003774. PubMed ID: 38700045
[TBL] [Abstract][Full Text] [Related]
8. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
Perrotta C; Chahla J; Badariotti G; Ramos J
Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
Lin PT; Wang SH; Chi CC
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
[TBL] [Abstract][Full Text] [Related]
10. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.
Middleton P; Shepherd E; Gomersall JC
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001689. PubMed ID: 33779986
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation for perioperative thromboprophylaxis in people with cancer.
Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117
[TBL] [Abstract][Full Text] [Related]
14. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.
Mellon L; Doyle F; Hickey A; Ward KD; de Freitas DG; McCormick PA; O'Connell O; Conlon P
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012854. PubMed ID: 36094829
[TBL] [Abstract][Full Text] [Related]
15. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
[TBL] [Abstract][Full Text] [Related]
16. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
[TBL] [Abstract][Full Text] [Related]
17. Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients.
Chan S; Ng S; Chan HP; Pascoe EM; Playford EG; Wong G; Chapman JR; Lim WH; Francis RS; Isbel NM; Campbell SB; Hawley CM; Johnson DW
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013209. PubMed ID: 32799356
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
[TBL] [Abstract][Full Text] [Related]
19. Synbiotics, prebiotics and probiotics for solid organ transplant recipients.
Cooper TE; Scholes-Robertson N; Craig JC; Hawley CM; Howell M; Johnson DW; Teixeira-Pinto A; Jaure A; Wong G
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014804. PubMed ID: 36126902
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
